Cargando…
Microbiome, Mycobiome and Related Metabolites Alterations in Patients with Metabolic Syndrome—A Pilot Study
Metabolic syndrome (MetSyn) has a rapidly growing worldwide prevalence, affecting over 1 billion people. MetSyn is clustering many pathological conditions, which, untreated, could increase the risk and often lead to more severe metabolic defects such as type 2 diabetes and non-alcoholic fatty liver...
Autores principales: | Gradisteanu Pircalabioru, Gratiela, Ilie, Iuliana, Oprea, Luciana, Picu, Ariana, Petcu, Laura Madalina, Burlibasa, Liliana, Chifiriuc, Mariana-Carmen, Musat, Madalina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951583/ https://www.ncbi.nlm.nih.gov/pubmed/35323661 http://dx.doi.org/10.3390/metabo12030218 |
Ejemplares similares
-
Snapshot into the Type-2-Diabetes-Associated Microbiome of a Romanian Cohort
por: Gradisteanu Pircalabioru, Gratiela, et al.
Publicado: (2022) -
Effects of the Lipid Profile, Type 2 Diabetes and Medication on the Metabolic Syndrome—Associated Gut Microbiome
por: Gradisteanu Pircalabioru, Gratiela, et al.
Publicado: (2022) -
Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care
por: Nicu, Alina-Teodora, et al.
Publicado: (2022) -
Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer
por: Lazar, Veronica, et al.
Publicado: (2018) -
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
por: Lazar, Veronica, et al.
Publicado: (2019)